论文部分内容阅读
米利酮(milrinone)是1990年在荷兰上市的兼有血管扩张作用并能同时改善收缩和舒张功能异常的新型磷酸二酯酶Ⅲ(PDEⅢ)抑制剂,其临床研究较为活跃.本文就此药的药理与临床作一概述。
Milrinone is a new type of phosphodiesterase III (PDE Ⅲ) inhibitor which is listed in the Netherlands in 1990 and has vasodilator effect and can simultaneously improve systolic and diastolic dysfunction, and its clinical research is relatively active.In this paper, An overview with the clinical.